Abbott and st. jude medical broaden alliance for cardiovascular products in the united states

Abbott and St. Jude Medical announced Choice Alliance, a multi–year joint initiative that provides mutual U.S. customers access to a robust portfolio of interventional cardiology, cardiac rhythm management, electrophysiology and intravascular imaging and diagnostic technologies.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Pharma News

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Pharma News Articles

1 FDA approves Afrezza to treat diabetes Full Text FDA Press Announcements, June 30, 2014    Free full text

2 Duke team brings life-saving function to ketchup packets Duke University Health & Medicine News, July 3, 2014

3 FDA releases first-ever purple book for biosimilar characterization Full Text BioPharm International, October 3, 2014    Free full text

4 FDA releases guidance on OTC pediatric drug products Full Text BioPharm International, October 20, 2014    Free full text

5 Four ways to improve pharmacovigilance processes with automation Full Text Applied Clinical Trials, October 6, 2014    Free full text

6 Sanofi and Regeneron announce positive phase 2 top-line dupilumab results in patients with chronic sinusitis with nasal polyps Full Text Sanofi, October 3, 2014    Free full text

7 Bristol-Myers Squibb announces multiple regulatory milestones for Opdivo (nivolumab) in the U.S. and European Union Full Text Bristol Myers-Squibb, October 3, 2014    Free full text

8 Factors affecting the uptake of new medicines: A systematic literature review Full Text BMC Health Services Research, October 24, 2014    Free full text    Evidence Based Medicine    Review Article

9 Sarepta therapeutics announces publication of Ebola and Marburg phase I clinical study results in antimicrobial agents and chemotherapy Full Text Sarepta Therapeutics, October 17, 2014    Free full text

10 Crowdfunding: the open-source option against capital crunch Pharmaceutical Executive Magazine, October 17, 2014

11 Newly-approved empagliflozin for obese patients with type 2 diabetes First Report Managed Care, October 10, 2014

12 Boston scientific receives FDA and CE mark approval for new CoverEdge surgical leads for the precision Spectra™ Spinal Cord Stimulator (SCS) system Full Text Boston Scientific, October 24, 2014    Free full text

13 Efficacy of honey in reduction of post tonsillectomy pain, randomized clinical trial International Journal of Pediatric Otorhinolaryngology , October 24, 2014    Clinical Article
Exclusive Author Commentary

14 10 Reasons to make the Baltic States A location for your next clinical trial Full Text Applied Clinical Trials, October 17, 2014    Free full text

15 MedImmune and Cancer Research UK establish joint CRUK-MEDI Alliance Laboratory to develop new biologic cancer medicines Full Text AstraZeneca, October 3, 2014    Free full text

16 With an eye on growth, Agfa healthcare expands North American executive team Imaging Economics, October 3, 2014

17 Sanofi Pasteurs dengue vaccine candidate successfully completes final landmark phase III clinical efficacy study in Latin America Full Text Sanofi, October 10, 2014    Free full text

18 New report details players and pipelines in the biosimilar space Full Text BioPharm International, October 3, 2014    Free full text

19 Teva announces initiation of new drug application and positive results from second human abuse liability study for CEP-33237 (hydrocodone bitartrate) extended-release tablets Full Text Teva Pharmaceutical Industries, October 10, 2014    Free full text

20 Existing FDA pathways have potential to ensure early access to, and appropriate use of, specialty drugs Health Affairs, October 10, 2014    Review Article

Indexed Journals in Pharma News: U.S.Pharmacist, FDA Drug Alerts, Pharmiwebmore